ResearcherEMD Serono Research & Development Institute, Inc.Active in the last 2 years

Medical Responsible

Provisional: name at one institution (moderate confidence)As of 11 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Papers: 0
Trials: 2
Grants: 0
Collaborators: 0

Papers, trials and grants by year

2025: 1 trial · 2026: 1 trial

Trials 2

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors Study director NCT07360314 ↗
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors Study director NCT07166601 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.